Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets.
about
Inflammatory mediators of hepatic steatosis.FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats.Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patientsMisregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity.Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice.PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair.Regulation of bile acid and cholesterol metabolism by PPARsRole of pregnane X receptor in obesity and glucose homeostasis in male mice.Sex-specific metabolic interactions between liver and adipose tissue in MCD diet-induced non-alcoholic fatty liver disease.Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases.The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH.Biochemical mechanisms in drug-induced liver injury: certainties and doubts.Clostridium butyricum MIYAIRI 588 improves high-fat diet-induced non-alcoholic fatty liver disease in rats.Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis.Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation.The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms.
P2860
Q33734136-1950B754-CDC2-4E1E-8506-7509C64A58FCQ33741191-58219CD1-8DA1-4E9C-A224-083E2CEA369DQ33934261-E43F7B31-E521-4318-926E-9B0DD294906CQ36478196-6DE66834-A11E-45DF-B6CF-F3601B04900DQ37130242-306E6C4A-9D17-427F-A92E-4B0637B45FC6Q37187770-F19F7C1D-0414-4F13-8C23-01A71C3BBE16Q37266779-2605361E-06F3-4F22-A358-108096FB9AC6Q37563409-C06BCF35-995A-47AF-BBA4-8AB7E67DC3A5Q37565005-FB350B74-2D98-4F7B-8100-493C79D0F362Q37702088-7EEC5985-4334-4AD3-ABAA-185ABF2BE4D1Q37947064-A82CA702-0BC9-4533-9B42-D9F09D8213E7Q38752520-57827053-C3C0-4300-B42B-C5894B424E1EQ39304941-B1AF8BC6-E463-46BF-A97D-FC8B5B0A0ACDQ42588200-733F11AB-243E-402C-B9BF-75ADB6B9625EQ44598904-8F3B62A3-F3D7-48EE-9CF0-0D60817441BFQ46255944-9CDAE121-FE21-4FE5-B21C-F0F088D73524Q46390723-BD737432-4AFB-47AD-966C-43F3A853E551Q50201534-646FD5D6-1BD6-47ED-895E-9555F9E4AE45Q51373445-4D8B7987-7AD0-4795-8AE2-B8FAE007D7AFQ53023338-1D7E55AB-0325-42EE-9CC0-BF91AC63A42E
P2860
Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonalcoholic fatty liver disea ...... eptors as therapeutic targets.
@en
Nonalcoholic fatty liver disea ...... eptors as therapeutic targets.
@nl
type
label
Nonalcoholic fatty liver disea ...... eptors as therapeutic targets.
@en
Nonalcoholic fatty liver disea ...... eptors as therapeutic targets.
@nl
prefLabel
Nonalcoholic fatty liver disea ...... eptors as therapeutic targets.
@en
Nonalcoholic fatty liver disea ...... eptors as therapeutic targets.
@nl
P356
P1476
Nonalcoholic fatty liver disea ...... eptors as therapeutic targets.
@en
P2093
Christopher Liddle
Jacob George
P356
10.1021/MP700110Z
P407
P577
2007-12-12T00:00:00Z